Barry Labinger

Barry Labinger is the founder of Checkmate Pharmaceuticals. Checkmate Pharmaceuticals has raised $85M in total funding. Latest round: Series C.

About Barry Labinger

Barry Labinger is a biotech executive who served as President and CEO of Checkmate Pharmaceuticals, a clinical-stage biopharmaceutical company focused on cancer immunotherapy. He oversaw an $85 million Series C financing and a subsequent $75 million IPO for the company.

Barry Labinger at a glance

More founders in Cambridge, MA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library